You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
6 April 2022
Stada is extending its Eunova range of vitamins, minerals and supplements (VMS) in Germany with a Vitamin D3 Spray and a Junior version for children aged four years and older.
22 March 2022
Stada’s Consumer Healthcare segment reported sales up by 15% to EUR1.28 billion (USD1.40 billion) in 2021, accounting for two-fifths of the company’s total sales. The German company says it expects to “withstand the current economic issues in Russia”.
2 March 2022
Stada has welcomed a decision by the German health ministry to allow the antihistamine doxylamine to remain available without a prescription for use by people of all ages with sleep disorders, including those aged 65 years and older.
2 March 2022
Stada has expanded its Lemocin sore-throat medicine in Germany and received confirmation from the German health ministry that the original formulation containing the antibiotic mixture tyrothricin can remain available without a prescription.
24 February 2022
Stada has captured the OTCToolbox Consumer Healthcare Industry (CHi) Award for Business Development Team of the Year. The German company wins the CHi Award for the second year in a row.
24 February 2022
The OTCToolbox Consumer Healthcare Industry (CHi) Award for Sustainability Project of the Year goes to Natures Aid for its Wild Earth range of vitamins, minerals and supplements (VMS).
21 January 2022
Stada is supporting its ambitious growth plans in consumer healthcare and prescription pharmaceuticals by investing EUR48.3 million (USD54.5 million) in a new supply chain and packaging hub in Romania.
21 September 2021
Germany’s Stada has hired Weleda’s Marc van Boven as head of Consumer Health Germany.
9 September 2021
Germany’s Stada and Italy’s NTC have announced a commercial ophthalmic partnership in the Middle East and North Africa (MENA) region.
27 August 2021
Stada Nordic is boosting its consumer healthcare portfolio through a commercial partnership with Slovenia’s Medis Consumer Health covering its topical analgesic Rowiren.